A very elusive cousin to LSD, methylisopropyllysergamide (MiPLA) was originally synthesized by Albert Hofmann, but never ended up becoming as popular among psychedelic users.
MiPLA
Well-documented
Well-documented
Multiple authoritative sources agree on dosing and effects.
- 3 corroborating sources
- 1 ROA with full dose ladder
- duration data present
- 19 combo interactions documented
- PubChem toxicity data
- classified Research-chemical
- 3 corroborating sources
- 1 ROA with full dose ladder
- duration data present
- 19 combo interactions documented
- PubChem toxicity data
- classified Research-chemical
Aliases: Lamide
Summary
MiPLA is a research chemical with very limited history of human use and minimal scientific study of its pharmacology, metabolism, and toxicity. It is approximately two to three times less potent than LSD and has a notably shorter duration of around 4-6 hours. The substance is generally described as producing less anxiety and a lighter headspace compared to LSD, with more recreational and social characteristics.
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral | 100-150Β΅g | 150-200Β΅g | 200-250Β΅g | 300Β΅g+ |
Onset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset |
|---|---|---|---|---|
| Oral | 19-40 min | 45-90 min | 1-2 hrs | 1-2 hrs |
Effect Profile
7 reportsScores (1–10) curated from multiple sources:
- Effect keyword matching from PsychonautWiki catalog
- Weighted by importance: core (×3), major (×2), minor (×1)
Moderate headspace with mild visuals and body load
Tolerance
Tolerance Decay
Acute tolerance: develops within a single session β the reset numbers above apply after sustained heavy use, not after one binge. Within-session tachyphylaxis usually resets largely overnight.
Effects
Aggregated from 7 Erowid experience reports
Positive Effects 7
Adverse Effects 3
Combinations
Cross-Check MiPLA with another substanceCommunity Trip Reports
Anecdotal first-person accounts from Reddit, Erowid, and Bluelight. Click a source to expand. Reports are harm-reduction context, not medical guidance.
Erowid 4 reports 1 positive 3 neutral visit
July 27th, 2019 : 1st trial of MiPLA (200ug), bought from a reputable canadian vendor. I recently tried MiPLA for the first time. The reviews and anecdotic reports on this molecule were sparse, but all positive; saying it was a lighter, milder type of "acid".
25 May 2018: 1st Trial of alleged 200 ΞΌg MIPLA tabs from Poland Tripping well grounded This was a planned, much-anticipated first experience with MIPLA, a novel lysergamide. Novel to me certainly, with little hard documentation to go on. I had heard, on highest authority, MIPLA was a good one.
Setting: bedroom with s/o, watching television 8:13: 200ug MiPLA tab under the tongue, no taste, tab larger than most I've received 9:00 their definately is a hint of something coming on, colors are beginning to appear brighter, in better humor than usual, blankets feel extra soft.
Bluelight 1 thread 1 neutral visit
25 May 2018: 1st trial of alleged 200 ΞΌg MIPLA tabs from Poland This was a planned, much-anticipated first experience with MIPLA, a novel lysergamide. Novel to me certainly, with little hard documentation to go on. I had heard, on highest authority, MIPLA was a good one. Atypically, I did not test this material.
Bluelight Reference Guide
Lysergamides The Big & Dandy MIPLA (Methylisopropyllysergamide) Thread
iupac = (8Ξ²)-N-Isopropyl-N,6-dimethyl-9,10-didehydroergoline-8-carboxamide The production of this compound was hinted at by a very reputable source. There is next to nothing on this compound that I can find on the web, besides a single erowid article.
Read full thread on Bluelight βHelpful Links
Report an issue or suggest an edit
Spotted incorrect or dangerous information, have a correction, a new study, or a useful addition for MiPLA? Let us know. Reports are reviewed by moderators — this is not posted publicly.